Ngā hua rapu - Matthias A. Karajannis

Whakamahine hua
  1. 1
    Neurofibromatosis-related tumors

    Neurofibromatosis-related tumors mā Matthias A. Karajannis, Rosalie E. Ferner

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Treatment of pediatric brain tumors

    Treatment of pediatric brain tumors mā Matthias A. Karajannis, Jeffrey C. Allen, Elizabeth W. Newcomb

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Glioblastoma multiforme: State of the art and future therapeutics

    Glioblastoma multiforme: State of the art and future therapeutics mā DavidH. Harter, TaylorA Wilson, Matthias A. Karajannis

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Strict Lymphotropism of Epstein-Barr Virus During Acute Infectious Mononucleosis in Nonimmunocompromised Individuals

    Strict Lymphotropism of Epstein-Barr Virus During Acute Infectious Mononucleosis in Nonimmunocompromised Individuals mā Matthias A. Karajannis, Michael Hummel, I. Anagnostopoulos, H. Stein

    I whakaputaina 1997
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus

    Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus mā Wei Li, Jonathan M. Cooper, Matthias A. Karajannis, Filippo G. Giancotti

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma

    R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma mā Susan Williams, Matthias A. Karajannis, Luis Chiriboga, John G. Golfinos, Andreas von Deimling, David Zagzag

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape

    Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape mā Amar Gajjar, Daniel C. Bowers, Matthias A. Karajannis, Sarah Leary, Hendrik Witt, Nicholas G. Gottardo

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Treatment of Pediatric Low-Grade Gliomas

    Treatment of Pediatric Low-Grade Gliomas mā Sameer Farouk Sait, Alexandra Giantini-Larsen, Kathryn R. Tringale, Mark M. Souweidane, Matthias A. Karajannis

    I whakaputaina 2023
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors

    Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors mā Shiyang Wang, Benjamin Liechty, Seema Patel, Jeffrey S. Weber, Travis J. Hollmann, Matija Snuderl, Matthias A. Karajannis

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma

    ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma mā Sylwia Ammoun, Clare H. Cunliffe, Jeffrey C. Allen, Luis Chiriboga, Filippo G. Giancotti, David Zagzag, C. Oliver Hanemann, Matthias A. Karajannis

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation

    Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation mā Cordelia Orillac, Cheddhi Thomas, Yosef Dastagirzada, Eveline Teresa Hidalgo, John G. Golfinos, David Zagzag, Jeffrey H. Wisoff, Matthias A. Karajannis, Matija Snuderl

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2

    MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2 mā Cheng‐Ying Ho, Eli E. Bar, Caterina Giannini, Luigi Marchionni, Matthias A. Karajannis, David Zagzag, David H. Gutmann, Charles G. Eberhart, Fausto J. Rodriguez

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    The microtubule-targeting agent CA4P regresses leukemic xenografts by disrupting interaction with vascular cells and mitochondrial-dependent cell death

    The microtubule-targeting agent CA4P regresses leukemic xenografts by disrupting interaction with vascular cells and mitochondrial-dependent cell death mā Isabelle Petit, Matthias A. Karajannis, Loi͏̈c Vincent, Lauren M. Young, Jason M. Butler, Andrea T. Hooper, Koji Shido, Hermann Steller, David J. Chaplin, Eric J. Feldman, Shahin Rafii

    I whakaputaina 2007
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    <i>BRAF</i>Alterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549

    <i>BRAF</i>Alterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549 mā Alex Y. Lin, Fausto J. Rodríguez, Matthias A. Karajannis, Susan Williams, Geneviève Legault, David Zagzag, Peter C. Burger, Jeffrey C. Allen, Charles G. Eberhart, Eli E. Bar

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Bevacizumab in recurrent high-grade pediatric gliomas

    Bevacizumab in recurrent high-grade pediatric gliomas mā A. Narayana, Saroj Kunnakkat, Jeena Chacko-Mathew, Sharon L. Gardner, Matthias A. Karajannis, Shahzad Raza, Jeffrey H. Wisoff, Howard L. Weiner, David H. Harter, Jeffrey C. Allen

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Merlin/NF2 Loss-Driven Tumorigenesis Linked to CRL4DCAF1-Mediated Inhibition of the Hippo Pathway Kinases Lats1 and 2 in the Nucleus

    Merlin/NF2 Loss-Driven Tumorigenesis Linked to CRL4DCAF1-Mediated Inhibition of the Hippo Pathway Kinases Lats1 and 2 in the Nucleus mā Wei Li, Jonathan M. Cooper, Lü Zhou, Chenyi Yang, Hediye Erdjument‐Bromage, David Zagzag, Matija Snuderl, Marc Ladanyi, C. Oliver Hanemann, Pengbo Zhou, Matthias A. Karajannis, Filippo G. Giancotti

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target

    Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target mā Marianne Hütt-Cabezas, Matthias A. Karajannis, David Zagzag, Smit Shah, Iren Horkayne‐Szakaly, Elisabeth J. Rushing, J. Douglas Cameron, Deepali Jain, Charles G. Eberhart, Eric H. Raabe, Fausto J. Rodríguez

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas

    Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas mā Matthias A. Karajannis, Geneviève Legault, Mari Hagiwara, Marc Ballas, Krysten Brown, Annette O. Nusbaum, Tsivia Hochman, Judith D. Goldberg, Kevin M. Koch, John G. Golfinos, J. Thomas Roland, Jeffrey C. Allen

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas

    Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas mā Matthias A. Karajannis, Geneviève Legault, Mari Hagiwara, Filippo G. Giancotti, Alexander S. Filatov, Anna Derman, Tsivia Hochman, Judith D. Goldberg, Emilio Vega-Gonzales, Jeffrey H. Wisoff, John G. Golfinos, Amanda Merkelson, J. Thomas Roland, Jeffrey C. Allen

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway

    Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alteratio... mā Jason T. Huse, Matija Snuderl, David Jones, Carole Brathwaite, Nolan Altman, Ehud Lavi, Richard Saffery, Alexandra Sexton‐Oates, Ingmar Blümcke, David Capper, Matthias A. Karajannis, Ryma Benayed, Lukas Chávez, Cheddhi Thomas, Jonathan Serrano, Laetitia Borsu, Marc Ladanyi, Marc K. Rosenblum

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: